Dr. Kara Sheinart, MD

Dr. Sheinart practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Sheinart's NPI, 1366412660, was assigned on January 26, 2006. Dr. Sheinart graduated from State University of New York Downstate Medical Center in 1989. Dr. Sheinart holds New York license 182849.

Dr. Sheinart's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Sheinart also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Sheinart's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Sheinart to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheinart practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Sheinart's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Sheinart is licensed in New York.

CMS data shows 453 Medicare services from Dr. Sheinart across 6 procedure codes in 2024, for 152 Medicare patients. Medicare paid $26,713 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 152 Medicare patients who saw Dr. Sheinart in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sheinart's median patient age at 71, with 63% women.

In 2024, Dr. Sheinart wrote 165 Medicare Part D claims for 41 patients. 87% of them were for generic drugs. CMS names the drug for 131 of them, across 6 drugs with 11 or more claims each, at $13,982 in total drug cost. In 2023, CMS named 142 claims across 6 drugs.

Dr. Sheinart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sheinart as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Sheinart from 2 drug and device companies from 2018 to 2022. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $130.

Dr. Sheinart graduated from State University of New York Downstate Medical Center in 1989.